Weight loss is challenging, and achieving a healthy, ideal weight through diet and exercise alone can be especially difficult. For this reason, more and more patients turn to GIP/GLP-1 receptor blockers to help them achieve a healthier weight and maintain their new physique long-term. Also known by the brand names Ozempic, Wegovy, and Mounjaro these medications were initially developed to treat type 2 diabetes. In Chicago, Illinois, Dr. Skura offers GIP/GLP-1 treatment at Art Aesthetica.
A GIP/GLP-1 receptor blocker is an injectable prescription that has been proven to improve weight loss results when paired with a suitable diet and exercise. This treatment is often a good option for patients who are considered obese or chronically overweight. The active ingredient in this treatment is similar to the natural hormone incretin, which triggers the release of insulin in response to blood sugar increases, decreases the amount of sugar made by the liver, and aids in regulating the appetite. This makes it an effective treatment for patients with type 2 diabetes as well as those who wish to lose weight.
Prior to prescribing GIP/GLP-1 Receptor Blockers, Dr. Skura will carefully review your health history and goals for treatment to ensure that you are a safe and suitable candidate.
GIP/GLP-1 injections are initiated at the office under Dr. Skura’s care. The patient will be educated on how to administer at home, or if required may come for weekly injections to the office. These injections can be made to the thigh, abdomen, or upper arm. Injections should be given once per week. Over the course of most treatments, doses may gradually increase. Be sure to carefully follow Dr. Skura’s instructions regarding your dosage and the course of your treatment.
In addition to this treatment, patients should take care to follow a healthy diet and exercise routine to meet their weight loss goals. You can discuss a proper diet and exercise plan with Dr. Skura or another member of your healthcare team.
GIP/GLP-1 injections do not require extensive aftercare. Some common side effects can include swelling, redness, itchiness, or tenderness at the injection site. Some patients may also experience bruising. In addition, patients may experience nausea, vomiting, diarrhea, or constipation. If these side effects persist, you should contact Dr. Skura.
Improper dosage of GIP/GLP-1 or failing to intake sufficient calories or drink enough water can result in complications with blood sugar. Symptoms can include sweating, shaking, hunger, dizziness, or headache. If these occur, be sure to tell Dr. Skura, who can advise you on resolving the issue or adjust dosage.
Typically, patients begin to notice weight loss within about four weeks of their first injection. Dr. Skura can explain reasonable expectations during your consultation.